- Home
- INSE vs NTHI Comparison
INSE vs NTHI Comparison
Compare INSE & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INSE | NTHI |
|---|---|---|
| Founded | 2002 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.3M | 195.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | INSE | NTHI |
|---|---|---|
| Price | $9.07 | $7.02 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 182.0K | 71.7K |
| Earning Date | 11-05-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.93 | N/A |
| Revenue | ★ $309,900,000.00 | $59,990.00 |
| Revenue This Year | $4.17 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.66 | ★ N/A |
| Revenue Growth | ★ 4.98 | N/A |
| 52 Week Low | $6.51 | $3.20 |
| 52 Week High | $11.61 | $25.00 |
Technical Indicators
Market Signals| Indicator | INSE | NTHI |
|---|---|---|
| Relative Strength Index (RSI) | 59.97 | 37.62 |
| Support Level | $8.79 | $8.63 |
| Resistance Level | $9.34 | $10.44 |
| Average True Range (ATR) | 0.42 | 0.93 |
| MACD | 0.02 | -0.18 |
| Stochastic Oscillator | 61.26 | 15.35 |
Price Performance
Historical ComparisonAbout INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments, namely Gaming, Virtual Sports, Interactive, and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.
About NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).